• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi Board Member awarded title for his leadership in Malaysian COVID-19 response

Datuk Dr Noor Hisham Abdullah awarded the distinguished title of ‘Tan Sri’

Home > News

DNDi Board Member awarded title for his leadership in Malaysian COVID-19 response

Datuk Dr Noor Hisham Abdullah awarded the distinguished title of ‘Tan Sri’

Dr noor Hisham Awarded 'Tan Sri' Title
4 Sep 2020

DNDi Board Member and Malaysian Director General of Health, Datuk Dr Noor Hisham Abdullah was awarded the distinguished title of ‘Tan Sri’ on 17 August 2020, in conjunction with the Malaysian King, HRH Al-Sultan Abdullah Ri’ayatuddin Al-Mustafa Billah Shah’s official birthday celebrations.

This honorary royal title was awarded to recognise his leadership and service to the nation in the COVID-19 response. In Malaysia, Tan Sri Dato’ Seri Dr Noor Hisham Abdullah is widely regarded as a dependable, trusted and respectable figure who has helped steer, educate and enforce measures to contain the pandemic.

The title of ‘Tan Sri’ is the second highest civilian honour that can be granted in Malaysia. It is a close equivalent to a British knighthood or Grand Officer de la Legion d’ Honneur, France.

Upon receiving this award, Dr Noor Hisham said, ‘This special recognition also serves as a symbol of appreciation for all frontliners, civil servants and Malaysian Health Ministry staff in the fight against COVID-19.’

In the same week, Tan Sri Dato’ Seri Dr Noor Hisham Abdullah was also named the official annual recipient of the ‘2020/1442 Hijrah Tokoh Maal Hijrah’ (Maal Hijrah Icon Award). The Malaysian King, Sultan Abdullah Ri’ayatuddin Al-Mustafa Billah Shah awarded a medal and a certificate to Tan Sri on behalf of the Malaysian government where the Prime Minister, Tan Sri Muhyiddin Yassin was present to witness this event.

The Maal Hijrah Icon Award is presented yearly to individuals who exemplify noble acts and Islamic stewardship. This award is seen as a recognition by the Malaysian government for their individual and significant contributions in uplifting Islamic values and principles, both nationally and globally.

More information

  • The Star: “Health DG Dr Noor Hisham named national 2020 Tokoh Maal Hijrah”
  • Pejabat Perdana Menteri Malaysia: “Sambutan Maal Hijrah Peringkat Kebangsaan”
  • The Star: “Health DG is this year’s Tokoh Maal Hijrah”

Photo credit: BERNAMA (2020)

Pandemic Preparedness Malaysia

Read, watch, share

Loading...
Statements
19 May 2026

DNDi interventions at the 79th World Health Assembly

Dr Sergio Sosa-Estani
Statements
15 May 2026

DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’

Statements
13 May 2026

DNDi’s briefing note for 79th World Health Assembly

Close up of legs with sandals on a dry soil
Press releases
12 May 2026

DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai

Press releases
27 Apr 2026

Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients

Stories

Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases

News
31 Mar 2026

DNDi is looking for a Board Treasurer to join its Board of Directors

Title copy on white and orange background, picture of Fr Robinson on the right hand
Videos
26 Mar 2026

Manufacturing medicines for NTDs, with Dr Stephen Robinson

VIEW ALL

Help neglected patients

To date, we have delivered fourteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license